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Nowadays it is assumed that besides its roles in neuronal processing, dopamine (DA)
is also involved in the regulation of cerebral blood flow. However, studies on the
hemodynamic actions of DA have been mainly focused on the cerebral cortex, but the
possibility that vessels in deeper brain structures receive dopaminergic axons and the
origin of these axons have not been investigated. Bearing in mind the evidence of changes
in the blood flow of basal ganglia in Parkinson’s disease (PD), and the pivotal role of
the dopaminergic mesostriatal pathway in the pathophysiology of this disease, here we
studied whether striatal vessels receive inputs from midbrain dopaminergic neurons. The
injection of an anterograde neuronal tracer in combination with immunohistochemistry
for dopaminergic, vascular and astroglial markers, and dopaminergic lesions, revealed
that midbrain dopaminergic axons are in close apposition to striatal vessels and
perivascular astrocytes. These axons form dense perivascular plexuses restricted to
striatal regions in rats and monkeys. Interestingly, they are intensely immunoreactive for
tyrosine hydroxylase (TH) phosphorylated at Ser19 and Ser40 residues. The presence of
phosphorylated TH in vessel terminals indicates they are probably the main source of basal
TH activity in the striatum, and that after activation of midbrain dopaminergic neurons, DA
release onto vessels precedes that onto neurons. Furthermore, the relative weight of this
“vascular component” within the mesostriatal pathway suggests that it plays a relevant
role in the pathophysiology of PD.
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INTRODUCTION
DA is a neurotransmitter and neuromodulator involved in a
wide range of brain functions including control of voluntary
movements, reward-seeking behavior, cognitive processes and
circuit formation during development (Schultz, 2007; Money and
Stanwood, 2013; Morita et al., 2013). DA also exerts important
actions in peripheral organs, with those being on the vascular
dynamics control of particular relevance (Tayebati et al., 2011).
Studies carried out in the 1970s and 1980s showed that DA
and DA agonists have vasomotor effects on major extracerebral
arteries and pial arterioles of the cortical surface, promoting
a general increase in cerebral blood flow (Toda, 1976; Ingvar
et al., 1983; Edvinsson et al., 1985). More recently, it has been
shown that DA analogs also modify blood flow into discrete
brain regions (Breiter et al., 1997; Marota et al., 2000), and
that this effect is prevented by dopaminergic lesion (Chen et al.,
1997; Nguyen et al., 2000; Jenkins et al., 2004). In sum, the
involvement of DA in the regulation of regional cerebral blood
flow is well-established nowadays. However, our knowledge on
this issue is still fragmentary and relevant aspects have not been
elucidated. For example, while some data suggest that vascular
effects of DA require activation of postsynaptic D1 DA receptors
(Knutson and Gibbs, 2007), dopaminergic contacts have also been
described in small vessels of the monkey frontal cortex (Krimer
et al., 1998), and DA receptor expression has been found in
cultured endothelial cells and astrocytes (Bacic et al., 1991; Bal
et al., 1994; Zanassi et al., 1999; Choi et al., 2006), suggesting
a direct DA effect on vessels and surrounding astrocytes. On
the other hand, most interest in cerebral blood flow regulation
has been focussed on the cerebral cortex, whereas mechanisms
operating in deep brain centers, including the striatum, have been
less investigated. It is noteworthy that in spite of the striatum
being the main target of midbrain dopaminergic inputs, there
is no evidence that striatal vessels and surrounding astrocytes
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receive midbrain dopaminergic contacts. The clarification of this
question could contribute to a better understanding of metabolic
and hemodynamic events associated with striatal processing and
their role in the pathophysiology of Parkinson’s disease (PD). This
possibility has been explored here by using nigral injections of an
anterograde tracer in combination with immunofluorescence for
dopaminergic, vascular and astroglial markers, confocal microsp-
copy and dopaminergic lesion.
MATERIAL AND METHODS
Experiments were carried out on 16 male Sprague-Dawley
rats (250–300 g; Charles River, L’Arbresle, France) and three
male rhesus monkeys (Macaca fascicularis, 6–7 years old,
3.5–4.8 Kg). Nine rats were used for the injection of the antero-
grade neuronal tracer biotinylated dextran amine (BDA) in the
dopaminergic cell groups of ventral midbrain, and seven rats
for 6-hydroxydopamine (6-OHDA) lesion. The three monkeys
were processed for immunofluorescence. Experimental protocols
were approved by the Ethical committee of the University of
La Laguna (Reference # 091/010), and are in accordance with
the European Communities Council Directive of 22 September
2010 (2010/63/EU) regarding the care and use of animals for
experimental procedures.
SURGICAL PROCEDURES
BDA injections were performed according to Lanciego and
Wouterlood (2006). A 10% solution of BDA (biotin, dextran
10 kDa; Molecular Probes, Leiden, The Netherlands) in 10 mM
phosphate buffer pH 7.25 was iontophoretically delivered in the
midbrain dopaminergic formation (1.2–1.8 mm lateral to mid-
line, 5.7–6.0 mm posterior to bregma and 8.0–8.5 mm below
the dura, according to Paxinos and Watson, 1998) using a glass
micropipette (inner tip diameter 20–30 µm) and a positive-
pulsed direct current (7 s on/off) for 7 min. The micropipette was
left in place for 5 min before removal. Animals were killed 1 week
after injection.
A rat model based on the intracerebroventricular injection of
6-OHDA was used for dopaminergic lesion. This model causes
bilateral degeneration of mesostriatal dopaminergic neurons, and
a motor syndrome composed of hypokinesia, purposeless chew-
ing and catalepsy (Rodríguez et al., 2001; Rodríguez-Díaz et al.,
2001; González-Hernández et al., 2004). Rats were injected in
the third ventricle (midline, 2 mm posterior to bregma and
8 mm below the dura, according to Paxinos and Watson, 1998)
with vehicle (0.9% saline solution with 0.3 µg/µl ascorbic acid,
sham group, n = 3) or a single dose (400 µg) of 6-OHDA (6-
hydroxydopamine hydrochloride, Sigma, St. Luis, MO; in 8 µl
of vehicle per injection; 1 µl/min, 6-OHDA groups, n = 4).
Anesthesia, pre-surgery treatment and intraventricular injection
protocols followed Rodríguez et al. (2001). Bearing in mind that
the bilateral degeneration of DA-cells can cause adipsia and apha-
gia (Zigmond and Stricker, 1973), the intake of food and water
was monitored following the 6-OHDA injection. No body weight
loss was observed and rats were killed 2 weeks after injection.
TISSUE PROCESSING
Animals were deeply anesthetized with an overdose of sodium
pentobarbital and transcardially perfused with heparinized
ice-cold 0.9% saline (150 ml in rats, 1 l in monkeys) followed by
4% paraformaldehyde in phosphate buffer saline 0.1 M pH 7.4
PBS; 300 ml in rats and 2.5 l in monkeys). The brains were
then removed, the midbrain and forebrain blocks were stored
in the same fixative at 4◦C (8 h in rats and 18 h in monkeys),
cryoprotected in a graded series of sucrose-PBS solutions and
stored at−80◦C until processing. Coronal sections (25µm in rats,
40 µm in monkeys) were obtained with a freezing microtome,
collected in parallel series and processed for single and double
immunohistochemical labeling.
For detecting BDA-stained fibers, floating sections were
immersed for 30 min in 3% H2O2 to inactivate endogenous
peroxidase, washed several times in PBS, and then incubated for
90 min in either ExtrAvidin-peroxidase (1:5000, Sigma) or Cy2-
conjugated ExtrAvidin (1:1000; Amersham, Buckinghamshire,
England) and 0.3% TX-100 in PBS. In sections incubated in
ExtrAvidin-peroxidase, stained fibers were visible after immersion
for 5–10 min in 0.005% 3′-3′-diamiobenzidine tetrahydrochlo-
ride (DAB, Sigma) and 0.001% H2O2 in cacodylate buffer 0.5 N,
pH 7.6.
Sections incubated in Cy2-conjugated ExtrAvidin were washed
several times in PBS, and incubated for 60 min at room
temperature (RT) in 4% normal goat serum (NGS, Jackson
ImmunoResearch, West Grove, PA) in PBS, and overnight in
PBS containing 2% NGS and one of the primary antibod-
ies: mouse anti-tyrosine hyroxylase (TH) monoclonal anti-
body (Sigma, 1:12,000), rabbit anti-TH phosphorylated at Ser19
(THp19) polyclonal antibody (PhosphoSolutions, Aurora, CO,
1:2000), rabbit anti-THp31 polyclonal antibody (PhosphoSo-
lutions, 1:600), rabbit anti-THp40 polyclonal antibody (Phos-
phoSolutions, 1:600), goat anti-dopamine transporter (DAT)
polyclonal antibody (1:1000, Santa Cruz Biotechnology, Santa
Cruz, CA), mouse anti-endothelial nitric oxide synthase (eNOS)
monoclonal antibody (1:1000, Sigma), mouse anti-glial fibrilary
acidic protein (GFAP) monoclonal antibody (1:2000, Sigma), or
mouse anti-vimentin monoclonal antibody (1:400, Abcam, Cam-
brige, UK). Immunofluorescent labeling was visible after incuba-
tion for 3 h in Alexa Fluor 488-conjugated donkey anti-rabbit
IgG (1:150; Molecular Probes, OR) and Rhodamine (TRITC) -
conjugated goat anti-guinea-pig IgG (1:100; Jackson ImmunoRe-
search), Lissamine Rhodamine-conjugated donkey anti-goat IgG
(1:100; Jackson ImmunoResearch) or Lissamine Rhodamine-
conjugated goat anti-mouse IgG (1:100; Jackson ImmunoRe-
search) in PBS containing 1:200 NGS.
After several rinses, the sections were mounted on gelatinized
slides, air dried, coverslipped with Vectashield (Vector), and
examined under a confocal laser scanning microscopy system
(Olympus FV1000, Hamburg, Germany) using appropriate filters.
Sections were first examined using low-magnification lenses, and
the areas of interest were analyzed at high magnification (×63
oil-immersion Plan-Apochromat objective lens, NA 1.4) at a
resolution of 1024 × 1024 pixels, and acquired in Z-stack mode
(10µm total thickness, 6 z-steps). Selected high-resolution confo-
cal images were then deconvoluted by using the MetaMorph 6.1r 0
software (Molecular Devices, Downingtown, PA). Deconvolution
is a post-adquisition computational process for correcting the
optical blur inherent to any image adquisition system, restoring
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the appearance of original image with the highest degree of
confidence (Sibarita, 2005; Salin et al., 2008).
In addition, a quantitative analysis of double labeled terminals
(THp19-DAT and THp40-DAT) was performed in high magnifi-
cation images. Four striatal sections 100 µm apart were randomly
selected in five rats. Four vessel-centered 200 µm × 200 µm
square regions were also randomly selected in each section. Simple
and double labeled terminals were counted within 100 µm from
the putative border of the vessel. Data are expressed as the per-
centage of double labeled terminals per section ± standard error
of the mean.
RESULTS
Striatal terminals were studied in rats whose BDA injection was
restricted to the midbrain dopaminergic cell groups (substantia
nigra pars compacta (SNC) and ventral tegmental area (VTA),
Figure 1A). Cases with injection involving neighboring centers
were excluded. Consistent with previous reports (Gerfen et al.,
1987; Joel and Weiner, 2000), the regional distribution of striatal
BDA positive fibers varied with the location of the injection site.
Injections in VTA and/or the rostromedial region of the SNC
provided a terminal field preferentially localized in the ventral
striatum and the ventral part of the dorsal striatum, while after
injections in the caudolateral region of the SNC, terminals spread
out across the dorsal striatum.
Axons through the ventral and dorsal striatum showed col-
lateral fibers emitting terminals in close apposition to the wall
of blood vessels of diverse diameters (range 50–500 µm). They
usually arise in the form of individual branches that emit isolated
perivascular endings (Figures 1C,E,G), but sparse perivascular
terminal plexuses were also found (Figures 1B,D,F). Double
labeling for BDA and vimentin (a marker of intermediate fila-
ments present in vessels and astrocytes) or GFAP (an astroglial
marker) confirmed the presence of BDA-positive terminal and “en
passant” buttons abutted on the wall of striatal vessels (Figure 1H)
and astroglial cells wrapping them (Figure 1I).
In order to confirm the dopaminergic nature of this projec-
tion, striatal sections of BDA-injected rats were further processed
for TH (the rate-limiting enzyme in DA synthesis) and DAT.
For TH immunohistochemistry, antibodies against the native
(non-phosphorylated) as well as the phosphorylated forms of
TH at serine 19 (THp19), serine 31 (THp31) and serine 40
(THp40) were used. Immunochemistry for native TH resulted
in a diffuse striatal staining (Figure 2A), making it difficult to
identify double TH-BDA positive axons. Consistent with pre-
vious reports supporting the idea that under basal conditions
only a very small proportion of TH is phosphorylated (Haycock
et al., 1998; Salvatore et al., 2001; Bobrovskaya et al., 2004),
immunostaining for the phosphoryated TH (THp) forms was
significantly lower than for native TH, and was restricted to
discrete striatal regions. Thus, immunoreactivity for THp31 was
virtually undetected in our material (data not shown), and for
THp19 and THp40 was confined to the olfactory tubercle (OT),
the accumbens shell and small patches throughout the ventral
and dorsal striatum (Figures 2B,C). The similarity in shape and
distribution between THp patches and striosomes (see Graybiel
and Ragsdale, 1978) prompted us to perform double labeling for
THp19 or THp40 and mu-opioid receptor (a marker of strio-
somes; Desban et al., 1993). However, no colocalization between
both markers was found (Figure 2D), indicating that THp-rich
patches preferentially localize in the matriceal compartment of the
striatum. Interestingly, all the patches surround vascular profiles.
The combination of immunolabeling for THp (Ser19 or Ser40)
and two vessel markers, the endothelial form of nitric oxide
synthase (eNOS, Figure 2E) and vimentin (Figure 2F), confirmed
that THp-rich patches form dense terminal plexuses around
striatal vessels, even penetrating their external layers (Figures 2J,K
arrows). The presence of THp perivascular plexuses was also
explored in monkeys. As shown in Figures 2G–I, small and large
vessels in the ventral and dorsal striatum of monkeys were also
surrounded by dense plexuses of THp terminals. Furthermore,
double labeling for THp (Ser19 or Ser40) and GFAP in rats
showed that THp-terminals are in close apposition to perivascular
astroglial processes (Figures 2L,M arrows).
As previously reported (González-Hernández et al., 2004),
immunostaining for DAT showed a homogeneous field of well-
defined striatal terminals (Figure 3A). A low magnification
view of double labeling for DAT and THp (Ser 19 and Ser
40) in rats showed co-localization in practically all perivascu-
lar plexuses (Figures 3A–C). The count of double labeled ter-
minals at higher magnification revealed that within 100 µm
from striatal vessels, virtually 100% (98.4 ± 0.9%) of positive
THp19 terminals were immunoreactive for DAT, and 97.7 ±
1.1% of DAT terminals were also immunoreactive for THp19
(Figures 3D–F). Furthermore, 97.4 ± 0.8% of THp40 termi-
nals were immunoreactive for DAT, but THp40 immunore-
activity was not detected in 12.8 ± 1.3% of DAT termi-
nals. These findings confirm the dopaminergic nature of THp
plexuses and that both serine residues are phosphorylated in
most perivascular terminals. Further supporting the midbrain
dopaminergic origin of the THp-rich innervation of striatal
vessels, BDA-positive axons and perivascular terminals were
immunoreactive for both DAT (Figures 3G–I) and THp19
(Figures 3J–L) or THp40 (Figures 3M–O). Moreover, striatal
THp perivascular plexuses disappeared after midbrain dopamin-
ergic lesion in parallel with the loss of midbrain DA-cells
(6-OHDA, Figure 4). In sum, our results indicate that striatal
vessels receive midbrain dopaminergic inputs that form dense
perivascular plexuses of THp-rich terminals.
DISCUSSION
The cerebral blood flow is controlled by two major neurovascular
systems. One of them, known as the extrinsic system, consists of
fibers from sympathetic and parasympathetic extracranial gan-
glia and the sensory trigeminal ganglion that release different
vasoactive substances on the wall of extracerebral arteries and
pial arterioles for the regulation of the global cerebral perfu-
sion (Drake and Iadecola, 2007; Willie et al., 2014). The other
one, known as the intrinsic system, consists of fibers arising
from different neurons in the brain which project directly to
parenchymal microvessels or astroglial end-feet adjoining them
for the regulation of highly localized changes in blood flow
coupled with regional synaptic activity (Iadecola, 2004; Hamel,
2006; Drake and Iadecola, 2007; Attwell et al., 2010; Lecrux and
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FIGURE 1 | (A) Biotinylated dextran amine (BDA) injection in the
substantia nigra pars compacta (SNC) and ventral tegmental area (VTA)
of the rat. (B–G) BDA-positive fibers emitting terminals in close
apposition to striatal vessels, some of them in the form of individual
axons (C,E,G), and others forming sparse plexuses (B,D,F). (H,I)
Double labeling for BDA and vimentin (H) or GFAP (I) showing
terminals abutted on striatal vessels and surrounding astrocytes
(arrows in H and I). (D,G) Boxed areas in (B) and (E) respectively. The
number at the bottom right in (A) indicates the distance from the
interaural axis in millimeters. SNR, substantia nigra pars reticulata. v,
vessel lumen. Bar in (A), 1 mm; in B, 400 µm; in (F) (for D and F), 150
µm; in (G), 100 µm; in (I) (for H and I), 100 µm.
Hamel, 2011). This system, preferentially studied in the cerebral
cortex, involves local GABAergic, peptidergic and glutamatergic
collaterals, as well as cholinergic, noradrenergic and serotonin-
ergic ascending inputs (Attwell and Iadecola, 2002; Cauli et al.,
2004; Iadecola, 2004; Lecrux and Hamel, 2011). The use of
anterograde tracers, specific neurotoxins and electron microscopy
shows that these projections come from the nucleus basalis, locus
coeruleus, and raphe nuclei respectively (Reinhard et al., 1979;
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FIGURE 2 | (A–C) Immunostaining for the non-phosphorylated (TH; A) and
phosphorylated forms of tyrosine hydroxylase at Ser19 (THp19; B) and
Ser40 (THp40; C) in rat striatum. We note that in contrast to the
homogeneous labeling for TH (A), THp19 and THp40 immunostaining is
restricted to the olfactory tubercle (OT), accumbens shell (AcbS), and
discrete regions throughout the ventral (vSt) and dorsal (dSt) striatum. (D)
Double labeling for mu-opioid receptor (mu, a marker of striosomes; red)
and THp40 (green) showing that THp40 is not localized in striosomes. (E,F)
Double labeling for endothelial nitric oxide synthase (eNOS; E, red) or
(Continued )
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FIGURE 2 | Continued
vimentin (Vim; F, red) and THp19 (green) showing dense plexuses of
THp19-positive terminals surrounding longitudinal- (E) and transversally (F)
cut vessels. (G) Immunostaining for THp40 in the monkey striatum
showing intense immunoreactivity in perivascular terminals. (H,I) Boxed
areas in (G). (J) Double labeling for vimentin (Vim; red) and THp40 (green)
in rat striatum subjected to deconvolution processing. (K) Boxed area in (J)
showing THp40 terminals in close apposition to or penetrating (arrows) the
vessel wall (arrows). (L) Double labeling for GFAP (red) and THp19 (green) in
rat striatum subjected to deconvolution processing. (M) Boxed area in (L)
showing THp19 terminals touching astroglial processes (arrows). Doted line
in (A–C) indicates the putatitve border between vSt and dSt. The number at
the bottom right in (A–C,G) indicates the distance from the interaural axis in
millimeters. AcbC, accumbens core; Pu, putamen; v, vessel lumen. Bar in
(C) (for A–C), 450 µm; in (D), 200 µm; in (E), 75 µm; in (F), 75 µm; in (G),
3 mm; in (I) (for H and I), 1 mm; in (J), 50 µm; in (K), 20 µm; in (L), 50 µm;
in (M), 20 µm.
Vaucher and Hamel, 1995; Cohen et al., 1997), and that their
endings make contact with both the components of the neurovas-
cular unit, the vessel wall and surrounding astrocytes (Vaucher
and Hamel, 1995; Cohen et al., 1997). Dopaminergic neurotrans-
mission has also been implicated in both neurovascular regulatory
systems. Firstly, through in vitro and in situ studies showing
that DA and its analogs promote vasoactive changes in convex-
ity cerebral arteries and pial arterioles (Toda, 1976; Edvinsson
et al., 1978a,b, 1985; Forster et al., 1983), and more recently,
from the evidence of dopaminergic contacts in capillaries and
perivascular astrocytes (Krimer et al., 1998), and the induction of
hemodynamic changes in discrete brain regions by dopaminergic
drugs (Marota et al., 2000; Choi et al., 2006; Sander et al., 2013)
and their inhibition after dopaminergic lesion (Chen et al., 1997;
Nguyen et al., 2000; Jenkins et al., 2004). However, the anatomical
origin of dopaminergic inputs to intracerebral vessels has not
been elucidated. The results here, based on the injection of an
anterograde neuronal tracer, combination of vessel, astrocyte and
dopaminergic markers, confocal microscopy and dopaminergic
lesion, indicate that striatal vessels receive inputs from mid-
brain dopaminergic neurons. We are aware that only electron
microscopy provides high enough magnification to properly iden-
tify synaptic structures. Nevertheless, high-resolution confocal
laser scanning followed by adequate post-adquisition computer
processing markedly reduces the resolution gap between optical
and electron microscopies (Sibarita, 2005; Salin et al., 2008).
Thus, one can suggest that, similar to dopaminergic and non-
dopaminergic inputs to cortical vessels (Vaucher and Hamel,
1995; Cohen et al., 1997; Krimer et al., 1998), ascending dopamin-
ergic terminals make contact with both components of the neu-
rovascular unit in the rat striatum. In any case, we know that
besides the synaptic transmission which requires interneuronal
contacts, neurotransmitters and neuromodulators, including DA,
can signal through extrasynaptic receptors after flowing short or
long distances in the extracellular space. Interestingly, electron
microscopy studies show that 50% of DA D1 and D2 recep-
tors in the rat striatum are extrasynaptic (Yung et al., 1995),
suggesting that most dopaminergic afferents can operate via
both synaptic and extrasynaptic receptors. According to Fuxe
et al. (2012), this sort of intercellular communication called
volume transmission (Agnati et al., 1986), is the main commu-
nication pathway in neuroglial and neurovascular interactions.
The evidence of DA D1 and D2 receptors in endothelial and
astroglial cells (Bacic et al., 1991; Bal et al., 1994; Zanassi et al.,
1999; Choi et al., 2006), together with the time (0–2 s) of
vascular response to DA release in the striatum (Knutson and
Gibbs, 2007) agree with the suggestion of Fuxe et al. (2012),
and therefore the evidence of terminal contacts becomes less
relevant.
Our results further show that dopaminergic axons innervating
striatal vessels form dense perivascular plexuses immunoreac-
tive for phosphorylated TH at Ser19 and Ser40. We know that
phosphorylation is the primary mechanism responsible for short-
term activation of TH, the rate-limiting enzyme of catecholamine
synthesis, and that TH may be phosphorylated by different pro-
tein kinases at four serine residues (8, 19, 31 and 40) near N-
terminus (Haycock and Wakade, 1992; Dunkley et al., 2004;
Nakashima et al., 2009). However, under basal conditions no
more than 5–7% TH is phosphorylated, and a substantial pro-
portion of TH becomes phosphorylated only after protein kinase
activating stimuli (Pocotte et al., 1986; Haycock, 1993; Haycock
et al., 1998; Salvatore et al., 2001; Bobrovskaya et al., 2004).
Consistent with these data, Xu et al. (1998) reported reduced
immunoreactivity for phosphorylated TH in comparison with
that for the native form, with phosphorylation being restricted
to Ser19 and localized in the accumbens nucleus and the OT. Our
results confirm these findings but enlarging them show that TH
is also constitutively phosphorylated in dopaminergic terminals
encircling vessels throughout the ventral and dorsal striatum. In
addition, as demonstrated in rats and monkeys, phosphorylation
also involves Ser40 residue.
The functional meaning and advantages of having multiple
phosphorylatable positions have not been yet elucidated (for
review see Daubner et al., 2011), but there is a general consensus
in that Ser40 is critical for TH activity. Thus, while no activa-
tion mechanisms and functional consequences have been found
for phosphorylation at Ser8 and phosphorylation at Ser19 and
Ser31 promote no more than 2-fold increases in TH activity,
phosphorylation at Ser40 results in a 300-fold decrease in TH
affinity for catecholamines with a 20-fold increase in TH activity
(Bevilaqua et al., 2001; Bobrovskaya et al., 2004; Dunkley et al.,
2004; Daubner et al., 2011). In addition, although Ser19 phos-
phorylation “per se” does not significantly affect TH activity, it
modifies TH structure thereby accelerating its phosphorylation at
Ser40 (Bevilaqua et al., 2001). Consequently, one can assume that
dopaminergic terminals with TH phosphorylated at Ser19 and
Ser40 are responsible for the basal TH activity in the striatum,
and that their DA content ready to be released is higher than in
those without phosphorylated TH.
Studies about the striatal processing in associative learn-
ing indicate that the activity of striatal neurons in each trial
is preceded by adaptive local hemodynamic changes which
are mediated by DA (Knutson and Gibbs, 2007; Peterson and
Seger, 2013). Midbrain dopaminergic neurons fire in response
to reward-predicting cues leading to an increase in extracellular
DA levels in the striatum (Roitman et al., 2004). Changes in
extracellular DA levels are paralleled by an increase in the regional
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FIGURE 3 | (A–C) A low magnification view of double labeling for the
dopamine transporter (DAT) and THp19 in the dorsal striatum of the rat.
(D–F) Boxed areas in (A), (B) and (C) respectively showing that all
perivascular THp19 fibers and terminals are dopaminergic
(DAT-immunoreactive). (G–O) Double labeling for DAT, THp19 or THp40 and
BDA showing that BDA-positive ascending axons (H) and perivascular
terminals (K,N) are immunoreactive for DAT (G–I), THp19 (J–L) and THp40
(M–O). v, vessel lumen. Dotted lines in (M–O) indicate the probable
localization of the vessel wall. Bar in (C) (for A–C), 130 µm; in (F) (for D–F),
40 µm; in (I) (for G–I), 40 µm; in (O) (for J–O), 40 µm.
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FIGURE 4 | (A,B) Immunohistochemistry for TH in the rat midbrain after
sham (A) and 400 µg 6-OHDA (B) intracerebroventricular injection. (C,D)
Immunofluorescence for THp19 in the striatum of sham (C) and 400 µg
6-OHDA (D) injected rats. One can see the decrease in the number of
TH-positive midbrain cells after 6-OHDA injection (compare A and B), and
that THp-19 striatal perivascular plexuses disappear after midbrain DA-cell
degeneration (compare C and D). ac, anterior commissure; OT, olfactory
tubercle; III, fibers of the third cranial nerve emerging in the surface of the
ventral midbrain. Numbers at the bottom right indicate the distance from
the interaural axis in millimeters. Bar in (B) (for A and B), 1 mm; in (D) (for C
and D), 1 mm.
cerebral blood flow that is inhibited by dopaminergic lesion
(Chen et al., 1997; Nguyen et al., 2000; Mandeville et al., 2001;
Jenkins et al., 2004). Consequently, the prior release of DA in
discrete striatal regions is nowadays considered a key factor in the
regulation of blood flow depending on local metabolic demands.
It is notable that dopaminergic signaling has also been involved in
anticipatory hemodynamic changes in the cerebral cortex (Tan,
2009). However, in the light of our and previous results, this
should be quite different to that in the striatum. In contrast to the
conspicuous perivascular plexuses involving small to large vessels
from the OT to the dorsal striatum, dopaminergic terminals
are sparse and restricted to small vessels in the cerebral cortex
(Krimer et al., 1998). Furthermore, as shown in rats and monkeys,
TH is not constitutively phosphorylated in vessel terminals in
the cerebral cortex. The restricted localization of phosphorylated
TH in dopaminergic terminals of striatal vessels suggests that
it is related to specific aspects of striatal processing. As shown
in Figure 5, a striatal neurovascular unit and the neighboring
neuropil probably receive projections from the same midbrain
neuron. Consequently, dopaminergic inputs should reach both
compartments at the same time. However, the fact that dopamin-
ergic terminals in perivascular plexuses contain phosphorylated
TH facilitates that the release of DA onto vessels precedes that
onto the neighboring neuropil, and then, that DA vascular actions
precede DA neuronal (non phosphorylated TH) actions.
FIGURE 5 | Schematic drawing summarizing the main results of this
study. Dopaminergic terminals on vessels contain phosphorylated TH while
those on striatal neurons and afferents contain non-phosphoryated TH,
suggesting that DA release onto vessels precedes DA release onto
neurons.
We know that the striatum receives the most intense dopamin-
ergic input in the brain, and that DA actions are exerted through
different DA-receptors in striatal neurons and cortical and subcor-
tical afferents arriving to different striatal regions (Obeso et al.,
2008). In addition, the loss of DA signaling in striatal circuits is
considered to cause motor symptoms as well as less noticeable
cognitive and psychiatric manifestations of PD (Rodriguez-Oroz
et al., 2009). However, as our results show, an important con-
tingent of dopaminergic axons reaches striatal vessels rather than
neurons, suggesting that these axons can play a role in the patho-
physiology of PD. Beyond the concept of vascular parkinsonism
(Kalra et al., 2010), the relationship between genuine PD and
cerebral perfusion has mostly been focused on whether vascular
co-morbidities can aggravate motor symptoms as a result of addi-
tive effects of two independent disorders (Kotagal et al., 2014),
or the possibility that vascular aspects can act synergistically with
other factors contributing to dopaminergic cell degeneration. In
support of the latter, morphological changes have been found in
nigral vessels of PD patients and animal models of PD (Faucheux
et al., 1999; Barcia et al., 2005), and the density of nigral
microvessels has also been found to be low in aged rats (Villar-
Cheda et al., 2009). In addition, recent studies by Rodriguez-
Perez et al. (2013) reveal that chronic brain hypoperfusion can
“per se” induce dopaminergic cell degeneration and exacerbate the
degeneration promoted by intrastriatal injection of 6-OHDA. Our
findings suggest that independently of the vascular involvement
in dopaminergic degeneration, the striatal blood flow can also be
substantially affected as a result of dopaminergic cell degenera-
tion. Consequently, the supply of oxygen and nutrients coupled
to hemodynamic changes preceding neuronal activity might also
be altered in the striatum, contributing as an additional factor
in the pathophysiology of PD from its first stages. Interestingly,
although the relationship between neuronal activity and oxygen
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consumption is the basis of functional imaging technologies
widely used in the diagnosis of PD (Mahlknecht et al., 2010),
nowadays blood flow is considered to merely serve as a metabolic
support in this paradigm (Moore and Cao, 2008). Moreover,
changes in striatal perfusion in the course of PD are still a matter
of controversy. While some authors report an increase of the
regional blood flow (Wolfson et al., 1985; Feigin et al., 2002; Hsu
et al., 2007), others find no changes (Bissessur et al., 1997) or
a decrease (Markus et al., 1994; Van Laere et al., 2004). These
discrepancies reflect differences in data processing and the clinical
profile of patients studied. In this respect, Imon et al. (1999)
found a decrease in striatal blood flow at early stages of PD, and
an increase at later stages, suggesting that changes can depend
on the disease stage. Bearing in mind the relative weight of the
“vascular component” in the mesostriatal pathway, it is possible
that hemodynamic changes may be detected and monitored from
the early stages of PD with the systematic use of functional
imaging.
ACKNOWLEDGMENTS
This work was supported by Ministerio de Ciencia e Innovación
(grant no. BFU2010-21130). Javier Castro-Hernández was sup-
ported by a predoctoral fellowship from Fundación Canaria de
Invetigación y Salud, Josmar Salas-Hernández by a grant from the
Gobierno Autónomo de Canarias, and Pedro Barroso-Chinea by a
grant from The Excellence Tri-continental Atlantic Campus (Uni-
versity of La Laguna) and the IMBRAIN project (FP7-REGPOT-
2012-CT2012-31637-IMBRAIN), funded by the 7th Framework
Program (Capacities).
REFERENCES
Agnati, L. F., Fuxe, K., Zoli, M., Ozini, I., Toffano, G., and Ferraguti, F. (1986). A
correlation analysis of the regional distribution of central enkephalin and beta-
endorphin immunoreactive terminals and of opiate receptors in adult and old
male rats. Evidence for the existence of two main types of communication in the
central nervous system: the volume transmission and the wiring transmission.
Acta Physiol. Scand. 128, 201–207. doi: 10.1111/j.1748-1716.1986.tb07967.x
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., and
Newman, E. S. (2010). Glial and neuronal control of brain blood flow. Nature
468, 232–243. doi: 10.1038/nature09613
Attwell, D., and Iadecola, C. (2002). The neuronal basis of functional brain imaging
signals. Trends Neurosci. 25, 621–625. doi: 10.1016/s0166-2236(02)02264-6
Bacic, F., Uematsu, S., McCarron, R. M., and Spatz, M. (1991). Dopaminergic
receptors linked to adenylate cyclase in human cerebromicrovascular endothe-
lium. J. Neurochem. 57, 1774–1780. doi: 10.1111/j.1471-4159.1991.tb06380.x
Bal, A., Bachelot, T., Savasta, M., Manier, M., Verna, J. M., Benabid, A. L., et al.
(1994). Evidence for dopamine D2 receptor mRNA expression by striatal astro-
cytes in culture: in situ hybridization and polymerase chain reaction studies.
Brain Res. Mol. Brain Res. 23, 204–212. doi: 10.1016/0169-328x(94)90227-5
Barcia, C., Bautista, V., Sanchez-Bahillo, A., Fernandez-Villalba, E., Faucheux, B.,
Poza y Poza, M., et al. (2005). Changes in vascularization in substantia nigra
pars compacta of monkeys rendered parkinsonian. J. Neural Transm. 112, 1237–
1248. doi: 10.1007/s00702-004-0256-2
Bevilaqua, L. R. M., Graham, M. E., Dunkley, P. R., von Nagy-Felsobuki, E. I., and
Dickson, P. W. (2001). Phosphorylation of ser(19) alters the conformation of
tyrosine hydroxylase to increase the rateod phosphorylation of ser(40). J. Biol.
Chem. 276, 40411–40416. doi: 10.1074/jbc.m105280200
Bissessur, S., Tissingh, G., Wolters, E. C., and Scheltens, P. (1997). rCFB SPECT in
Parkinson’s disease patients with mental dysfuction. J. Neural Transm. Suppl. 50,
25–30. doi: 10.1007/978-3-7091-6842-4_3
Bobrovskaya, L., Dunkley, P. R., and Dickson, P. W. (2004). Phosphorylation of
ser19 increases both ser40 phosphorylation and enzyme activity of tyrosine
hydroxylase in intact cells. J. Neurochem. 90, 857–864. doi: 10.1111/j.1471-4159.
2004.02550.x
Breiter, H. C., Gollub, R. L., Weisskoff, R. M., Kennedy, D. N., Makris, N., Berke,
J. D., et al. (1997). Acute effects of cocaine on human brain activity and emotion.
Neuron 19, 591–611. doi: 10.1016/s0896-6273(00)80374-8
Cauli, B., Tong, X. K., Rancillac, A., Serluca, N., Lambolez, B., Rossier, J., et al.
(2004). Cortical GABA interneurons in neurovascular coupling: relays for sub-
cortical vasoactive pathways. J. Neurosci. 24, 8940–8949. doi: 10.1523/jneurosci.
3065-04.2004
Chen, Y. C., Garpern, W. R., Brownell, A. L., Matthews, R. T., Bogdanov, M.,
Isacson, O., et al. (1997). Detection of dopaminergic neurotransmitter activity
using pharmacologic MRI: correlation with PET microdyalisis and behavioural
data. Mag. Res. Med. 38, 389–398. doi: 10.1002/mrm.1910380306
Choi, J.-K., Chen, Y. I., Hamel, E., and Jenkins, B. G. (2006). Brain hemodynamic
changes mediated by dopamine receptors: role of the cerebral microvascula-
ture in dopamine-mediated neurovascular coupling. Neuroimage 30, 700–712.
doi: 10.1016/j.neuroimage.2005.10.029
Cohen, Z., Molinatti, G., and Hamel, E. (1997). Astroglial and vascular interactions
of noradrenaline terminals in the rat cerebral cortex. J. Cereb. Blood FlowMetab.
17, 894–904. doi: 10.1097/00004647-199708000-00008
Daubner, S. C., Le, T., and Wang, S. (2011). Tyrosine hydroxylase and regulation of
dopamine synthesis. Arch. Biochem. Biophys. 508, 1–12. doi: 10.1016/j.abb.2010.
12.017
Desban, M., Kemel, M. L., Glowinski, J., and Gauchy, C. (1993). Spatial organi-
zation of patch and matrix compartments in the rat striatum. Neuroscience 57,
661–671. doi: 10.1016/0306-4522(93)90013-6
Drake, C. T., and Iadecola, C. (2007). The role of neuronal signalling in controlling
cerebral blood flood. Brain Lang. 102, 141–152. doi: 10.1016/j.bandl.2006.08.
002
Dunkley, P. R., Bobrovskaya, L., Graham, M. E., von Nagy-Felsobuki, E. I., and
Dickson, P. W. (2004). Tyrosine hydroxylase phosphorylation: regulation and
consequences. J. Neurochem. 91, 1025–1043. doi: 10.1111/j.1471-4159.2004.
02797.x
Edvinsson, L., Hardebo, J.-E., McCulloch, J., and Owman, C. (1978a). Effects of
dopaminergic agonists on isolated cerebral blood vessels. Acta Physiol. Scand.
104, 349–359. doi: 10.1111/j.1748-1716.1978.tb06286.x
Edvinsson, L., Hardebo, J.-E., McCulloch, J., and Owman, C. (1978b). “Vasomotor
response of the cerebral blood vessels to dopamine and dopaminergic agonists,”
in Advances in Neurology. Vol. 20: Pathology of Cerebrospinal Microcirculation,
eds J. Cervós-Navarro, E. Betz, G. Ebhardt, R. Ferszt and R. Wüllenweber (New
York: Raven Press), 85–96.
Edvinsson, L., McCulloch, J., and Shankey, J. (1985). Vasomotor response of cere-
bral arterioles in situ to putative dopamine receptor agonists. Br. J. Pharmacol.
85, 403–410. doi: 10.1111/j.1476-5381.1985.tb08875.x
Faucheux, B. A., Bonnet, A. M., Agid, Y., and Hirsch, E. C. (1999). Blood vessels
change in the mesencephalon of patients with Parkinson’s disease. Lancet 353,
981–982. doi: 10.1016/s0140-6736(99)00641-8
Feigin, A., Antonini, A., Fukuda, M., De Notaris, R., Benti, R., Pezzoli, G., et al.
(2002). Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of
parkinsonim. Mov. Disord. 17, 1265–1270. doi: 10.1002/mds.10270
Forster, C., Drew, G. M., Hilditch, A., and Whalley, E. T. (1983). Dopamine
receptors in human basilar arteries. Eur. J. Pharmacol. 87, 227–235. doi: 10.
1016/0014-2999(83)90332-1
Fuxe, K., Borroto-Escuela, D. O., Romero-Fernandez, W., Diaz-Cabiale, Z., Rivera,
A., Ferraro, L., et al. (2012). Extrasynaptic neurotransmission in the modulation
of brain function. Focus on the striatal neuronal-glial networks. Front. Physiol.
3:136. doi: 10.3389/fphys.2012.00136
Gerfen, C. R., Herkenham, M., and Tribault, J. (1987). The neostriatal
mosaic: II. Path- and matrix-directed mesostriatal dopaminergic and non-
dopaminergic systems. J. Neurosci. 7, 3915–3934. Available online at:
http://www.jneurosci.org/content/7/12/3915.long.
González-Hernández, T., Barroso-Chinea, P., De La Cruz-Muros, I., Perez-Delgado,
M. M., and Rodriguez, M. (2004). Expression of dopamine and vesicu-
lar monoamine transporters and differential vulnerability of mesostriatal
dopaminergic neurons. J. Comp. Neurol. 479, 198–215. doi: 10.1002/cne.20323
Graybiel, A. M., and Ragsdale, C. W. (1978). Histochemically distinct com-
partments in the striatum of human, monkey and cat demonstrated by
acetylcholinesterase staining. Proc. Natl. Acad. Sci. U S A 75, 5723–5726. doi: 10.
1073/pnas.75.11.5723
Frontiers in Neuroanatomy www.frontiersin.org August 2014 | Volume 8 | Article 84 | 9
Afonso-Oramas et al. Phosphorylated TH-rich innervation of striatal vessels
Hamel, E. (2006). Perivascular nerves and the regulation of cerebrovascular tone.
J. Appl. Physiol. 100, 1059–1064. doi: 10.1152/japplphysiol.00954.2005
Haycock, J. W. (1993). Multiple signalling pathways in bovine chromaffin cells
regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31 and Ser40. Neu-
rochem. Res. 18, 15–26. doi: 10.1007/bf00966919
Haycock, J. W., Lew, J. Y., Garcia-Espana, A., Lee, K. Y., Harada, K., Meller,
E., et al. (1998). Role of serine-19 phosphorylation in regulating tyrosine
hydroxylase studied with site- and phosphospecific antibodies and site-directed
mutagenesis. J. Neurochem. 71, 1670–1675. doi: 10.1046/j.1471-4159.1998.
71041670.x
Haycock, J. W., and Wakade, A. R. (1992). Activation and multiple-site phosphory-
lation of tyrosine hydroxylase in perfused rat adrenal glands. J. Neurochem. 58,
57–64. doi: 10.1111/j.1471-4159.1992.tb09276.x
Hsu, J.-L., Jung, T.-P., Hsu, C.-Y., Hsu, W.-C., Chen, Y.-K., Duann, J.-R., et al.
(2007). Regional CBF changes in Parkinson’s disease: a correlation with
motor dysfunction. Eur. J. Nucl. Med. Mol. Imaging 34, 1458–1466. doi: 10.
1007/s00259-006-0360-7
Iadecola, C. (2004). Neurovascular regulation in the normal brain and in
Alzheimer’s disease. Nat. Rev. Neurosci. 5, 347–360. doi: 10.1038/nrn1387
Imon, Y., Matsuda, H., Ogawa, M., Kogure, D., and Sunohara, N. (1999).
SPECT image analysis using statistical parametric mapping in patients
with Parkinson’s disease. J. Nucl. Med. 40, 1583–1589. Available online at:
http://jnm.snmjournals.org/content/40/10/1583
Ingvar, M., Lindvall, O., Folbergrová, J., and Siesjö, B. K. (1983). Influence of lesions
of the noradrenergic locus coeruleus system on the cerebral metabolic response
to bicuculline-induced seizures. Brain Res. 264, 225–231. doi: 10.1016/0006-
8993(83)90820-x
Jenkins, B. G., Sanchez-Penaute, R., Brownell, A. L., Chen, Y. C., and Isacson,
O. (2004). Mapping dopamine fuction in primates using pharmacological
magnetic resonance imaging. J. Neurosci. 24, 9553–9560. doi: 10.1523/jneurosci.
1558-04.2004
Joel, D., and Weiner, I. (2000). The connections of the dopaminergic system with
the striatum in rats and primates: an analysis with respect to the functional and
compartmental organization of the striatum. Neuroscience 96, 451–474. doi: 10.
1016/S0306-4522(99)00575-8
Kalra, S., Grosset, D. G., and Benamer, H. T. (2010). Differentiating vascular
parkinsonism from idiopathic Parkinson’s disease: a systematic review. Mov.
Disord. 25, 149–156. doi: 10.1002/mds.22937
Knutson, B., and Gibbs, S. E. B. (2007). Linking nucleus accumbens dopamine
and blood oxygenation. Psychopharmacology (Berl) 191, 813–822. doi: 10.
1007/s00213-006-0686-7
Kotagal, V., Albin, R. L., Müller, M. L., Koeppe, R. A., Frey, K. A., and Bohnen,
N. I. (2014). Modifiable cardiovascular risk factors and axial motor impair-
ments in Parkinson’s disease. Neurology 82, 1514–1520. doi: 10.1212/wnl.
0000000000000356
Krimer, L. S., Muly, E. C., Williams, G. V., and Goldman-Rakic, P. S. (1998).
Dopaminergic regulation of cerebral cortical microcirculation. Nat. Neurosci. 1,
286–289. doi: 10.1038/1099
Lanciego, J. L., and Wouterlood, F. G. (2006). “Multiple neuroanatomical tract-
tracing: approaches for multiple tract-tracing,” in Neuroanatomical Tract-
Tracing 3. Molecules, Neurons and Systems, eds L. Zaborszky, F. G. Wouterlood
and J. L. Lanciego (New York: Springer), 336–365.
Lecrux, C., and Hamel, E. (2011). The neurovascular unit in brain function and
disease. Acta Physiol. 203, 47–59. doi: 10.1111/j.1748-1716.2011.02256.x
Mahlknecht, P., Hotter, A., Hussl, A., Esterhammer, R., Schocke, M., and Seppi, K.
(2010). Significance of MRI in diagnosis and differential diagnosis of Parkinson’s
disease. Neurodegener. Dis. 7, 300–318. doi: 10.1159/000314495
Mandeville, J. B., Jenkins, B. G., Kosofsky, B. E., Moskowitz, M. A., Rosen, B. R.,
and Marotta, J. J. (2001). Regional sensitivity and coupling of BOLD and CBV
changes during stimulation of rat brain. Magn. Reson. Med. 45, 443–447. doi: 10.
1002/1522-2594(200103)45:3<443::aid-mrm1058>3.0.co;2-3
Markus, H. S., Costa, D. C., and Lees, A. J. (1994). HMPAO SPECT in Parkin-
son’s disease before and after levodopa: correlation with dopaminergic respon-
siveness. J. Neurol. Neurosurg. Psychiatry 57, 180–185. doi: 10.1136/jnnp.57.
2.180
Marota, J. J. A., Mandeville, J. B., Weisskoff, R. M., Moskowitz, M. A., Rosen,
B. R., and Kosofsky, B. E. (2000). Cocaine activation discriminates dopaminergic
projections by temporal response: an fMRI study in rat. Neuroimage 11, 13–23.
doi: 10.1006/nimg.1999.0520
Money, K. M., and Stanwood, G. D. (2013). Developmental origins of brain
disorders: roles for dopamine. Front. Cell. Neurosci. 7:260. doi: 10.3389/fncel.
2013.00260
Moore, C. I., and Cao, R. (2008). The hemo-neural hypothesis: on the role of blood
flow in information processing. J. Neurophysiol. 99, 2035–2047. doi: 10.1152/jn.
01366.2006
Morita, K., Morishima, M., Sakai, K., and Kawaguchi, Y. (2013). Dopamin-
ergic control of motivation and reinforcement learning: a closed circuit
account for reward-oriented behavior. J. Neurosci. 33, 8866–8890. doi: 10.
1523/JNEUROSCI.4614-12.2013
Nakashima, A., Hayashi, N., Kaneko, Y. S., Mori, K., Sabban, E. L., Nagatsu, T.,
et al. (2009). Role of N-terminus of tyrosine hydroxylase in the biosynthesis
of caecholamines. J. Neural Transm. 116, 1355–1362. doi: 10.1007/s00702-009-
0227-8
Nguyen, T. V., Brownell, A. L., Iris Chen, Y. C., Livni, E., Coyle, J. T., Rosen, B. R.,
et al. (2000). Detection of the effects of dopamine receptor supersensitivity using
pharmacological MRI and correlation with PET. Synapse 36, 57–65. doi: 10.
1002/(sici)1098-2396(200004)36:1<57::aid-syn6>3.0.co;2-k
Obeso, J. A., Rodriguez-Oroz, M. C., Benitez-Temino, B., Blesa, F. J., Guridi, J.,
Marin, C., et al. (2008). Functional organization of the basal ganglia: therapeutic
implications for Parkinson’s disease. Mov. Disord. 23(Suppl. 3), S548–S559.
doi: 10.1002/mds.22062
Paxinos, G., and Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates.
Orlando: Academic Press.
Peterson, E. J., and Seger, C. A. (2013). Many hats: intratrial and reward level-
dependent BOLD activity in the striatum and promoter cortex. J. Neurophysiol.
110, 1689–1702. doi: 10.1152/jn.00164.2012
Pocotte, S. L., Holz, R. W., and Ueda, T. (1986). Cholonergic receptor-mediated
phosphorylation and activation of tyrosine hydroxylase in cultured bovine
adrenal chromaffin cells. J. Neurochem. 46, 610–622. doi: 10.1111/j.1471-4159.
1986.tb13011.x
Reinhard, J. F. Jr., Liebmann, J. E., Schlosberg, A. J., and Moskowitz, M. A. (1979).
Serotonin neurons project to small blood vessels in the sbrain. Science 206, 85–
87. doi: 10.1126/science.482930
Rodríguez, M., Barroso-Chinea, P., Abdala, P., Obeso, J., and Gonzalez-Hernandez,
T. (2001). Dopamine cell degeneration induced by intraventricular administra-
tion of 6-hydroxydopamine in the rat: similarities with cell loss in Parkinson’s
disease. Exp. Neurol. 169, 163–181. doi: 10.1006/exnr.2000.7624
Rodríguez-Díaz, M., Abdala, P., Barroso-Chinea, P., Obeso, J., and Gonzalez-
Hernandez, T. (2001). Motor behavioural changes after intracerebroventricular
injection of 6-hydroxydopamine in the rat: an animal model of Parkinson’s
disease. Behav. Brain. Res. 122, 79–92. doi: 10.1016/s0166-4328(01)00168-1
Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard,
E., et al. (2009). Initial clinical manifestations of Parkinson’s disease: features
and pathophysiological mechanisms. Lancet Neurol. 8, 1128–1139. doi: 10.
1016/S1474-4422(09)70293-5
Rodriguez-Perez, A. I., Dominguez-Meijide, A., Lanciego, J. L., Guerra, M. J., and
Labandeira-Garcia, J. L. (2013). Dopaminergic degeneration is enhanced by
chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.
Age 35, 1675–1690. doi: 10.1007/s11357-012-9470-2
Roitman, M. F., Stuber, G. D., Phillips, P. E. M., Wightman, R. M., and Carelli,
R. M. (2004). Dopamine operates as a subsecond modulator of food seeking.
J. Neurosci. 24, 1265–1271. doi: 10.1523/jneurosci.3823-03.2004
Salin, P., Castle, M., Kachidian, P., Barroso-Chinea, P., López, I. P., Kerkerian-Le
Goff, L., et al. (2008). High-resolution neuroanatomical tract-tracing for the
analysis of striatal microcircuits. Brain Res. 1221, 49–58. doi: 10.1016/j.brainres.
2008.05.011
Salvatore, M. F., Waymire, J. C., and Haycock, J. W. (2001). Depolarization-
stimulated catecholamine biosynthesis: involvement of protein kinases and
tyrosine hydroxylase phosphorylation sites in situ. J. Neurochem. 79, 349–360.
doi: 10.1046/j.1471-4159.2001.00593.x
Sander, C. Y., Hooker, J. M., Catana, C., Normandin, M. D., Alpert, N. M.,
Knudsen, G. M., et al. (2013). Neurovascular coupling to D2/D3 dopamine
receptor occupancy using simultaneous PET/fuctional MRI. Proc. Natl. Acad.
Sci. U S A 110, 11169–11174. doi: 10.1073/pnas.1220512110
Schultz, W. (2007). Multiple dopamine functions at different time courses. Annu.
Rev. Neurosci. 30, 259–288. doi: 10.1146/annurev.neuro.28.061604.135722
Sibarita, J.-B. (2005). Deconvolution microscopy. Adv. Biochem. Eng. Biotechnol. 95,
201–243. doi: 10.1007/b102215
Frontiers in Neuroanatomy www.frontiersin.org August 2014 | Volume 8 | Article 84 | 10
Afonso-Oramas et al. Phosphorylated TH-rich innervation of striatal vessels
Tan, C. O. (2009). Anticipatory changes in regional cerebral hemodynamics: a new
role for dopamine?. J. Neurophysiol. 101, 2738–2740. doi: 10.1152/jn.00141.2009
Tayebati, S. K., Lokhandwala, M. F., and Amenta, F. (2011). Dopamine and vasculat
dynamics control: present status and future perspectives. Curr. Neurovasc. Res.
8, 246–257. doi: 10.2174/156720211796558032
Toda, N. (1976). Influence of dopamine and noradrenaline on isolated cerebral
arteries of the dog. Br. J. Pharmacol. 58, 121–126. doi: 10.1111/j.1476-5381.1976.
tb07700.x
Van Laere, K., Santens, P., Bosman, T., De Reuck, J., Mortelmans, L., and Dierckx,
R. (2004). Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic
Parkinson’s disease and multiple system atrophy with predominant parkinso-
nian features: correlation with clinical parameters. J. Nucl. Med. 45, 933–942.
Available online at: http://jnm.snmjournals.org/content/45/6/933
Vaucher, E., and Hamel, E. (1995). Cholinergic basal forebrain neurons project
to cortical microvessels in the rat: electron microscopic study with antero-
grade transported Phaseolus vulgaris leucoagglutinin and choline acetyltrans-
ferase immunocytochemistry. J. Neurosci. 15, 7427–7441. Available online at:
http://www.jneurosci.org/content/15/11/7427.long
Villar-Cheda, B., Sousa-Ribeiro, D., Rodriguez-Pallares, J., Rodriguez-Perez, A. I.,
Guerra, M. J., and Labandeira-Garcia, J. L. (2009). Aging and sedentarism
decrease vascularization and VEGF levels in the rat substantia nigra. Implica-
tions for Parkinson’s disease. J. Cereb. Blood Flow Metab. 29, 230–234. doi: 10.
1038/jcbfm.2008.127
Willie, C. K., Tzeng, Y.-C., Fisher, J. A., and Ainslie, P. N. (2014). Integrative regula-
tion of human brain blood flow. J. Physiol. 593, 841–859. doi: 10.1113/jphysiol.
2013.268953
Wolfson, L. I., Leenders, K. L., Brown, L. L., and Jones, T. (1985). Alterations of
regional cerebral blood flow and oxygen metabolism in Parkinson’s disease.
Neurology 35, 1399–1405. doi: 10.1212/wnl.35.10.1399
Xu, Z.-Q., Lew, J. Y., Harada, K., Aman, K., Goldstein, M., Deutch, A., et al. (1998).
Immunohistochemical studies on phosphorylation of tyrosine hydroxylase in
central catecholamine neurons using site- and phosphorylation state-specific
antibodies. Neuroscience 82, 727–738. doi: 10.1016/S0306-4522(97)
00189-9
Yung, K. K., Bolam, J. P., Smith, A. D., Hersch, S. M., Ciliax, B. J., and Levey, A. I.
(1995). Immunocytochemical localization of D1 and D2 dopamine receptors
in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65,
709–730. doi: 10.1016/0306-4522(94)00536-e
Zanassi, P., Paolillo, M., Montecucco, A., Avvedimento, E. V., and Schilelli, S.
(1999). Pharmacological and molecular evidence for dopamine D(1) receptor
expression by striatal astrocytes in culture. J. Neurosci. Res. 58, 544–552. doi: 10.
1002/(sici)1097-4547(19991115)58:4<544::aid-jnr7>3.0.co;2-9
Zigmond, M. J., and Stricker, E. M. (1973). Recovery of feeding and drinking by
rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
Science 182, 717–720. doi: 10.1126/science.182.4113.717
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 13 June 2014; accepted: 02 August 2014; published online: 26 August 2014.
Citation: Afonso-Oramas D, Cruz-Muros I, Castro-Hernández J, Salas-Hernández J,
Barroso-Chinea P, García-Hernández S, Lanciego JL and González-Hernández
T (2014) Striatal vessels receive phosphorylated tyrosine hydroxylase-rich
innervation from midbrain dopaminergic neurons. Front. Neuroanat. 8:84.
doi: 10.3389/fnana.2014.00084
This article was submitted to the journal Frontiers in Neuroanatomy.
Copyright © 2014 Afonso-Oramas, Cruz-Muros, Castro-Hernández, Salas-
Hernández, Barroso-Chinea, García-Hernández, Lanciego and González-Hernández.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums is
permitted, provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Neuroanatomy www.frontiersin.org August 2014 | Volume 8 | Article 84 | 11
